Status:
COMPLETED
SQ53 Disinfectant Wipes for Prevention of CRBSI
Lead Sponsor:
The Cleveland Clinic
Collaborating Sponsors:
JVS Products, Ltd.
Conditions:
Catheter-related Bloodstream Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
SQ53 is a novel antimicrobial, sporicidal solution that is based on a platform of quaternary ammonium chloride compounds. It has been tested against a wide range of bacteria, viruses, spores and funga...
Detailed Description
Parenteral nutrition (PN) therapy is an essential component of medical management of patients suffering from intestinal failure. Depending on the underlying etiology and the type of intestinal failure...
Eligibility Criteria
Inclusion
- Patients requiring home parenteral nutrition support via PICC line or tunneled CVC.
Exclusion
- Age less than 18 years
- Women known to be pregnant
- Women of childbearing age who are planning a pregnancy
- Women who are breastfeeding
- Patients who will not be managed by Cleveland Clinic HPN service
- Patients who refuse to use disinfectant wipes daily.
Key Trial Info
Start Date :
December 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 7 2022
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT04822467
Start Date
December 10 2021
End Date
December 7 2022
Last Update
June 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic
Cleveland, Ohio, United States, 44195